Sai Life Sciences Ltd

With a decisive surge to Rs 1243 on 12 Jun 2026, Sai Life Sciences Ltd has reached a fresh 52-week and all-time high, marking a 63.65% rally from its low of Rs 704.45 over the past year. This milestone is underscored by a strong alignment of technical indicators and sustained price momentum, setting the stock apart in a market where the broader Sensex has struggled.

Sai Life Sciences Ltd has reached a significant milestone by touching an all-time high price of Rs 1,224.55 on 12 June 2026, reflecting the company’s sustained strong performance in the Pharmaceuticals & Biotechnology sector. This achievement underscores the firm’s robust financial health and market resilience amid a challenging broader market environment.

Sai Life Sciences Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 10 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

With a sustained six-day rally culminating in a fresh 52-week high of Rs 1239.35 on 10 Jun 2026, Sai Life Sciences Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market by a significant margin.

Sai Life Sciences Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 9 June 2026 by hitting its all-time high stock price of Rs.1202. This achievement reflects the company’s robust financial performance and sustained upward momentum in the market.

With a sustained rally that has seen it climb from Rs 704.45 to a new peak of Rs 1202, Sai Life Sciences Ltd has demonstrated remarkable price momentum over the past year, outperforming the broader market by a wide margin.

Surging to a fresh 52-week and all-time high of Rs 1200 on 8 Jun 2026, Sai Life Sciences Ltd has demonstrated remarkable price momentum, outpacing the broader market which remains under pressure. The stock’s recent four-day rally has delivered a 5.42% gain, pushing it well above all key moving averages and signalling robust technical health.

Sai Life Sciences Ltd has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early June 2026. Despite a modest decline in its share price, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a cautious outlook for investors in the Pharmaceuticals & Biotechnology sector.

Sai Life Sciences Ltd is rated Buy by MarketsMOJO, with this rating last updated on 02 Mar 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 30 May 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook.

With a decisive surge to Rs 1165.55 on 25 May 2026, Sai Life Sciences Ltd has reached a fresh 52-week and all-time high, extending its impressive 61.85% rally over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance versus the broader market indices.

Sai Life Sciences Ltd has reached an all-time high price of Rs 1,164.70 on 25 May 2026, underscoring the company’s robust performance in the Pharmaceuticals & Biotechnology sector. This milestone reflects sustained growth and strong market positioning, with the stock outperforming key benchmarks and demonstrating resilience across multiple time frames.

With a remarkable 51.57% gain over the past year, Sai Life Sciences Ltd has surged to a fresh 52-week high of Rs 1159.35 on 21 May 2026, significantly outperforming the Sensex which declined by 7.27% during the same period. This milestone reflects a sustained momentum driven by a confluence of robust technical indicators and steady fundamental growth.

With every major technical indicator aligned to the upside, Sai Life Sciences Ltd surged to a fresh 52-week high of Rs 1159.35 on 21 May 2026, marking a significant milestone in its price momentum journey.

Sai Life Sciences Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 21 May 2026 by touching its all-time high stock price of Rs. 1,159.35. This achievement reflects the company’s robust financial performance and sustained growth over recent quarters.

Surging to an intraday peak of Rs 1149.85 on 20 May 2026, Sai Life Sciences Ltd has marked a significant milestone by reaching a fresh 52-week high. This achievement caps a sustained rally that has seen the stock appreciate 55.77% over the past year, comfortably outperforming the Sensex, which has declined 7.53% in the same period.

Extending its winning streak to three sessions, Sai Life Sciences Ltd surged 1.82% on 20 May 2026 to touch a fresh all-time high of Rs 1,146, outpacing the Sensex which declined 0.28% on the day. This rally marks a continuation of strong momentum that has propelled the stock to outperform its sector and broader market over multiple timeframes.

Sai Life Sciences Ltd is rated Buy by MarketsMOJO, with this rating last updated on 02 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 May 2026, providing investors with the latest insights into the company’s performance and outlook.